Author

Elisavet Kalaitsidou

Agency for Science, Technology and Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

Wei WuiD· 3 shared Jan J. MolenaariD· 2 shared John AndersoniD· 2 shared Josephine G. M. StrijkeriD· 2 shared Judith WienkeiD· 2 shared Alicia TayiD· 1 shared Arjan BoltjesiD· 1 shared Basil Kuok Zi XiiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Wei WuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multi-omics and functional analysis of a bioengineered vascularized pancreatic cancer model reveal an immunosuppressive and therapy-resistant niche

Giulio Giustarini, Kok Siong Ang, Pavanish Kumar, Germaine Teng, Basil Kuok Zi Xi, Chong Xiang Tan, Ragini Bhalla, Elisavet Kalaitsidou, Alicia Tay, Shanshan Wu Howland, Paola Cappello, Wei Wu, Jinmiao Chen, Salvatore Albani, Giulia Adriani

The paper develops a bioengineered vascularized pancreatic cancer model and uses multi-omics and functional assays to reveal an immunosuppressive and therapy-resistant tumor niche.

bioRxiv · Mar 9, 2026 · PreprintCancer Biology

Proteomic profiling of the neuroblastoma secretome identifies extracellular vesicles as drivers of T cell suppression

Josephine G. M. Strijker, Ronja E. van Berkum, Elisavet Kalaitsidou, Arjan Boltjes, Naima Hiddink Verberne, Mirjam J. A. Damen, Femke van den Ham, Liselotte E. Baaij, John Anderson, Jan J. Molenaar, Wei Wu, Judith Wienke

The paper identifies extracellular vesicles as immunosuppressive factors in neuroblastoma by profiling secretomes and showing their ability to suppress T cell activation.

bioRxiv · Dec 3, 2025 · PreprintCancer Biology

Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma

Josephine G. M. Strijker, Guillem Pascual‐Pasto, Grant P. Grothusen, Yannine J. Kalmeijer, Elisavet Kalaitsidou, Chunlong Zhao, Brendan C. McIntyre, Stephanie Matlaga, Lindy L. Visser, Marta Barisa, Courtney Himsworth, Rivani Shah, Henrike P. Muller, Linda G. Schild, Peter G. Hains, , Judith Wienke

This study identifies MIF as a key immunosuppressive factor in neuroblastoma that inhibits CAR T-cell efficacy, showing that blocking MIF enhances T-cell activation and therapeutic potential.

European Journal of Cancer · Jan 27, 2025Peer-reviewedCancer Biology